How the Pandemic Impacted Prostate Cancer Diagnostics
A senior medical director for Quest Diagnostics discusses how the pandemic impacted prostate cancer diagnostics and how it will impact clinical labs.
Read MorePosted by Chris Wolski | Jan 14, 2022 | Prostate |
A senior medical director for Quest Diagnostics discusses how the pandemic impacted prostate cancer diagnostics and how it will impact clinical labs.
Read MorePosted by Andy Lundin | Jan 13, 2022 | Immunoassay Reagents & test Kits |
During a month-long mission, around 4,000,000 testing kits will be delivered to the respective state authorities for distribution.
Read MorePosted by Andy Lundin | Jan 13, 2022 | Respiratory Disease |
Tech to advance the control of tuberculosis in areas with limited infrastructure has been approved by the Global Fund’s Expert Review Panel for Diagnostics.
Read MorePosted by Andy Lundin | Jan 12, 2022 | Immunoassay Reagents & test Kits |
Private health insurers will soon be required to cover COVID-19 tests for those they are covering, the Biden administration announced.
Read MorePosted by Andy Lundin | Jan 12, 2022 | Molecular Diagnostics |
BD, Pfizer, and global charitable foundation Wellcome are collaborating to highlight how diagnostic best practices can improve patient care.
Read More